Incidence of Thromboembolism in COVID-19 Infection in the ICU: a Retrospective Cohort Analysis

Ayse Zeynep Turan1 site in 1 country484 target enrollmentJanuary 1, 2022

ConditionsCOVID-19-Associated Thromboembolism

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: COVID-19-Associated Thromboembolism
Sponsor: Ayse Zeynep Turan
Enrollment: 484
Locations: 1
Primary Endpoint: Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.

Detailed Description

Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.

Registry

clinicaltrials.gov

Start Date

January 1, 2022

End Date

August 30, 2023

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ayse Zeynep Turan

Responsible Party

Sponsor Investigator

Principal Investigator

Ayse Zeynep Turan

Principle Investigator

Derince Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

•Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021

Exclusion Criteria

•who is under 18 years old.

Outcomes

Primary Outcomes

Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

Time Frame: During the entire intensive care stay up to 1 day

Both arterial and venous thromboembolic events were detected

Secondary Outcomes

Rate of thromboembolic complications of COVID-19 disease in critically ill patients(During the entire intensive care stay up to 1 day)
What is the rate of thromboembolism according to the comorbidities(During the entire intensive care stay up to 1 day)
Rate of thromboembolic complications according to anticoagulant therapy(During the entire intensive care stay up to 1 day)